Lupin receives European Commission approval for biosimilar ranibizumab RanluspecTM EP News Bureau Feb 23, 2026 Following positive CHMP opinion, Lupin to commercialise RanluspecTM in EU through Sandoz partnership
Lupin announces licensing deal for Ranibizumab biosimilar EP News Bureau Aug 12, 2025 Lupin will manufacture and file regulatory submissions, while Sandoz will commercialise the biosimilar across select global…
